Publications

5530 Results

BCG versus adriamycin in bladder cancer: A Southwest Oncology Group study.

Authors
DL Lamm;ED Crawford
Journal / Conference
ASCO :#C-424
Year
1985
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8216/38

BCG versus adriamycin in the treatment of transitional cell carcinoma in-situ: A Southwest Oncology Group study.

Authors
DL Lamm;ED Crawford
Journal / Conference
Proc AUA 133:184A (#283)
Year
1985
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8216/38

Intravesical adriamycin for recurrent superficial bladder cancer: A Southwest Oncology Group study.

Authors
ED Crawford;DL Lamm;JE Montie;PT Scardino;HB Grossman;T Stanisic;JA Smith;JW Sullivan
Journal / Conference
Proc AUA 133:213A (#397)
Year
1985
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8216/38

Phase II trial of combination chemotherapy in patients with extragonadal germ cell tumors: A Southwest Oncology Group study.

Authors
RM Bukowski;J Montie
Journal / Conference
AACR, #658
Year
1985
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8231

Concurrent chemotherapy with VP-16/vincristine/adriamycin/cyclophosphamide (EVAC) versus alternating chemotherapy with VP-16/cis-platinum and vincristine/adriamycin/cyclophosphamide(VPP/VAC) in limited small cell lung cancer (SCLC): A Southwest Oncology Group (SWOG) study.

Authors
GE Goodman;J Basko
Journal / Conference
Proc ASCO 5:169 (#663)
Year
1985
Research Committee(s)
Lung
Study Number(s)
SWOG-8232

A Phase II study of spirogermanium in central nervous system tumors: A Southwest Oncology Group study.

Authors
W Goodwin;B Tranum;W Slavik;R Vance
Journal / Conference
ASCO, #C-517
Year
1985
Research Committee(s)
Brain
Study Number(s)
SWOG-8239

Phase II of VM-26 and ifosfamide in refractory adult acute lymphocytic leukemia (ALL). A Southwest Oncology Group study.

Authors
D Ryan;J Bickers;J Athens;C Coltman, Jr
Journal / Conference
ASCO, #C-599
Year
1985
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8243

Phase I study of whole abdominal XRT plus concomitant bolus 5-FU as adjuvant therapy in Duke's B2C colon cancer: A Southwest Oncology Group study.

Authors
C Fabian;E Reddy;W Jewell;A Trowbridge
Journal / Conference
ASCO, #C-331
Year
1985
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8263

Concurrent chemoradiotherapy for limited small cell carcinoma of the lung (SCCL). A Southwest Oncology Group limited institutional pilot study.

Authors
JD McCracken;L Janaki;SA Taylor;GB Weiss
Journal / Conference
ASCO, #C-683
Year
1985
Research Committee(s)
Lung
Study Number(s)
SWOG-8269

Short term treatment of poor prognosis metastatic breast cancer with three alternating chemotherapy regimens: A Southwest Oncology Group pilot study.

Authors
FR Ahmann;R Pugh
Journal / Conference
ASCO, #C-264
Year
1985
Research Committee(s)
Breast and Genitourinary
Study Number(s)
SWOG-8278